Novartis (NYSE: NVS) reported Q1 EPS of $1.27, $0.05 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $13.74 billion versus the consensus estimate of $13.95 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.

Earnings